» Articles » PMID: 32171559

Epidemiology and Risk Factors for Community Associated Clostridioides Difficile in Children

Overview
Journal J Pediatr
Specialty Pediatrics
Date 2020 Mar 16
PMID 32171559
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess which risk factors are associated with community-associated Clostridioides difficile infection (CDI) in children.

Study Design: This case control study was a retrospective review of all children 1-17 years of age with stool specimens sent for C difficile testing from January 1, 2012, to December 31, 2016. Cases and controls were children who had C difficile testing performed in the community or first 48 hours of hospital admission and >12 weeks after hospital discharge, with no prior positive C difficile testing in last 8 weeks, without other identified causes of diarrhea, and with clinical symptoms. Cases had positive confirmatory testing for C difficile. Controls had negative testing for C difficile and were matched to cases 1:1 by age and year of specimen collection.

Results: The overall incidence rate of community-acquired CDI in this cohort was 13.7 per 100 000 children per year. There was a substantial increase in community-acquired CDI from 9.6 per 100 000 children per year in 2012 to a peak of 16.9 per 100 000 children per year in 2015 (Cochran-Armitage test for trend P = .002). The risk factors for community-acquired CDI included non-Hispanic ethnicity; amoxicillin-clavulanate, cephalosporin, and clindamycin use within the previous 12 weeks; a previous positive C difficile test within 6 months; and increased health care visits in the last year.

Conclusions: As rates of community-acquired CDI are increasing, enhanced antibiotic stewardship and recognition of health care disparities may ease the burden of community-acquired CDI.

Citing Articles

Clinical and economic outcomes associated with fidaxomicin in comparison to vancomycin, metronidazole, and FMT: A systematic literature review.

Li Q, Obi E, Marciniak A, Newman R, Whittle I, Kufakwaro J Medicine (Baltimore). 2025; 103(52):e39219.

PMID: 39969373 PMC: 11688082. DOI: 10.1097/MD.0000000000039219.


Gut Microbial and Metabolic Features Associated With Infection Recurrence in Children.

Li X, Xiao F, Wang X, Ye L, Xiao Y, Li D Open Forum Infect Dis. 2024; 11(9):ofae506.

PMID: 39319090 PMC: 11420671. DOI: 10.1093/ofid/ofae506.


Clinical Outcomes Associated with Amoxicillin Treatment for Acute Otitis Media in Children.

Frost H, Keith A, Fletcher D, Sebastian T, Dominguez S, Kurtz M J Pediatric Infect Dis Soc. 2024; 13(3):203-210.

PMID: 38314853 PMC: 11494229. DOI: 10.1093/jpids/piae010.


Interventions to de-implement unnecessary antibiotic prescribing for ear infections (DISAPEAR Trial): protocol for a cluster-randomized trial.

Jenkins T, Keith A, Stein A, Hersh A, Narayan R, Eggleston A BMC Infect Dis. 2024; 24(1):126.

PMID: 38267837 PMC: 10807124. DOI: 10.1186/s12879-023-08960-z.


Clostridium difficile infection in pediatric patients (Review).

Dop D, Marcu I, Padureanu V, Caragea D, Padureanu R, Niculescu S Biomed Rep. 2024; 20(2):18.

PMID: 38169799 PMC: 10758920. DOI: 10.3892/br.2023.1706.